India's AYUSH Premium Mark and NABL accreditation position it as global homoeopathy leader

Hindustan Times - India · 7 Mar 2026 · 2 min read
Prelims · Health Mains · GS2 Governance High relevance

India is emerging as a global leader in homoeopathy through AYUSH Premium Mark and NABL accreditation, challenging Germany's dominance with certified quality frameworks and large-scale practitioner networks.

Key points

AYUSH Premium Mark launched by Ministry of AYUSH ensures global-level compliance in manufacturing, safety, and quality management for homoeopathic products, enhancing India's international credibility.

NABL accreditation provides internationally benchmarked testing standards aligned with ISO norms, crucial for competing in regulated markets like Europe.

India has over 2.5 lakh registered homoeopathy practitioners and 300 teaching institutions, creating a robust ecosystem for research and clinical practice.

The global homoeopathy market is valued at USD 8-10 billion, with Europe historically dominated by German brands now facing competition from quality-certified Indian products.

Adven Biotech became India's first homoeopathy company to receive both AYUSH Premium Mark and NABL certification, demonstrating the framework's operational success.

[GS3-Economy] India's homoeopathy exports could grow 2-3 times in 5-7 years by penetrating premium European markets through certified quality frameworks.

[GS2-Governance] The certification systems address a key governance gap by providing scientific validation to traditional medicine, aligning with WHO's traditional medicine strategy 2014-2023.

India's cost-efficient production combined with certified quality creates competitive advantage against German brands in price-sensitive global markets.

Way Forward: Expand AYUSH Premium certification to more manufacturers, establish international homoeopathy research collaborations, and create a global marketing campaign for 'Certified Indian Homoeopathy' brand.

Key terms

AYUSH Premium Mark

A quality certification by India's Ministry of AYUSH for traditional medicine products ensuring compliance with international manufacturing, safety and quality standards. It enhances global market access for Indian homoeopathy by providing credible third-party validation comparable to European pharmacopoeia standards.

NABL accreditation

National Accreditation Board for Testing and Calibration Laboratories' certification that ensures testing laboratories meet international ISO standards. For homoeopathy, it validates product consistency and reliability - critical for export markets with stringent regulatory requirements like the EU.

Homoeopathy ecosystem

India's integrated network of 2.5 lakh practitioners, 300 colleges, research institutions and manufacturing units that form the world's largest homoeopathy infrastructure. This gives India comparative advantage in clinical data generation and large-scale production capacity.

German homoeopathy dominance

Germany's historical leadership in homoeopathy since its 18th century origins, maintained through strict pharmacopoeia standards and research investment. India's quality certification challenge this by combining traditional knowledge with modern quality systems.